ArticleBioinformation2026
Diagnostic treatment modalities premalignant oral lesions oral cancer progression impact: Comparative study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The best management of the oral potentially malignant disorders (OPMDs) remains uncertain particularly when subdivided into the levels of dysplasia. This retrospective cohort study involved 200 cases of patients who were compared with regard to malignant transformation and recurrence of malignancies between surgical excision and active surveillance. It was established that surgical excision had a substantially lower transformation risk, especially in moderate-to-severe dysplasia and had better malignancy-free survival on KaplanMeier analysis. Repeated cases were seen in both groups, but surveillance and high-grade dysplasia were found to be an independent powerful predictor of malignant progression. Thus, surgical excision offers meaningful protection in the transforming process and should be given priority with high-risk OPMDs to minimise the transition to OSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.